Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model

The emergence of SARS-CoV-2 variants, especially Beta and Delta, has raised concerns about the reduced protection from previous infection or vaccination based on the original Wuhan-Hu-1 (D614) virus. To identify promising regimens for inducing neutralizing titers towards new variants, we evaluated m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalnin, Kirill V., Plitnik, Timothy, Kishko, Michael, Huang, Dean, Raillard, Alice, Piolat, Julie, Anosova, Natalie G., Tibbitts, Timothy, DiNapoli, Joshua, Karve, Shrirang, Goldman, Rebecca, Gopani, Hardip, Dias, Anusha, Tran, Khang, Zacharia, Minnie, Gu, Xiaobo, Boeglin, Lianne, Abysalh, Jonathan, Vargas, Jorel, Beaulieu, Angela, Shah, Monic, Jeannotte, Travis, Gillis, Kimberly, Chivukula, Sudha, Swearingen, Ron, Landolfi, Victoria, Fu, Tong-Ming, DeRosa, Frank, Casimiro, Danilo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801978/
https://www.ncbi.nlm.nih.gov/pubmed/35101265
http://dx.doi.org/10.1016/j.vaccine.2022.01.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801978/
https://www.ncbi.nlm.nih.gov/pubmed/35101265
http://dx.doi.org/10.1016/j.vaccine.2022.01.021

Ejemplares similares